Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients

Clinical Cancer Research

Volumn 5, Issue 7, 1999, Pages 1843-1848

  Mellado, Begoña ^a   Gutierrez, Lorena ^a   Castel, Teresa ^a   Colomer, Dolors ^a   Fontanillas, Montserrat ^a   Castro, Josefa ^a   Estapé, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA CELL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM CIRCULATING CELLS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032766924     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Naito, H., Kuzumaki, N., Uchino, J-I., Kobayashy, R., Shikano, T., Ishikawa, Y., and Matsumoto, S. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur. J. Cancer, 27: 762-765, 1991.
2. Mattano, L. A., Moss, T. J., and Emerson, S. G. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res, 52: 4701-4705, 1992.
3. Datta, I. H., Adams, P. T., Drobyski, W. R., Ethier, S. P., Terry, V. H., and Roth, M. S. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol., 12: 475-482, 1994.
4. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G., and Comella, L. G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110-6112, 1992.
5. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplaw, I., Bubley, G., and De Wolf, W. Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634-2639, 1994.
6. Komeda, T., Fukuda, Y., Sando, T., Kita, R., Furukawa, M., Nishida, N., Amenomori, M., and Nakao, K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer (Phila.), 75: 2214-2219, 1995.
7. Matsumura, M., Niwa, Y., Kato, N., Shiina, S., Kawase, T., Toyoshima, H., Ihori, M., and Shiratori, Y. Detection of α-protein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology, 20: 1418-1425, 1995.
8. Hillaire, S., Barbu, V., Boucher, E., Moukhtar, M., and Poupow, R. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenteroloy, 106: 239-242, 1994.
9. Gerhard, M., Juhl, M., Kalthoff, H., Schreiber, H. W., Wagener, C., and Neumaier, M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J. Clin. Oncol., 12: 725-729, 1994.
10. Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, C., and Blair, G. E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet, 338: 1227-1229, 1991.
11. Hoon, D. S. B., Wang, Y., Dale, P. S., Conrad, A. J., Schmid, P., Garrison, D., Kuo, C., Foshag, L. J. Rizze, A. J., and Morton, D. L. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J. Clin. Oncol., 13: 2109-2116, 1995.
12. Brossart, P., Keilholz, U., Willhauck, M., Scheibenbogen, C., Mohler, T., and Hunstein, W. Hematogenous spread of malignant melanoma cells in different stages of disease. J. Invest. Dermatol., 101: 887-890, 1993.
13. Brossart, P., Shmier, J. W., Krüger, S., Willhauck, M., Scheibenbogen, C., Mohler, T., and Keilholz, V. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res., 55: 4065-4068, 1995.
14. Battayanni, Z., Grob, J., Xerri, L., PCR detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch. Dermatol., 131: 443-447, 1995.
15. Curry, B. J., Myers, K., and Hersey, P. Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment and recurrence from melanoma. J. Clin. Oncol., 16: 1760-1769, 1998.
16. Mellado, B., Colomer, D., Castel, T., Muñoz, M., Carballo, E., Galán, M., Moscero, J. M., Lives-Corrons, J. L., Grau, J. J., and Estopi, J. Detection of circulating neoplastic cells by RT-PCR in malignant melanoma. Correlation with clinical stage and prognosis. J. Clin. Oncol., 14: 2091-2097, 1996.
17. Farthmann, B., Ebverle, J., Krasagakis, K., Gstottner, M., Wang, N., Bisson, S., and Orfanes, C. E. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J. Invest. Dermatol., 110: 263-267, 1998.
18. Kunter, U., Buer, J., Probst, M., Dvernsing, S., Dallmann, I., Grosse, J., Kirchner, H., Schluepen, E. M., Volkenandt, M., Ganser, A., and Atzpidien, J. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J. Natl. Cancer Inst. (Bethesda), 88: 590-594, 1996.
19. Glaser, R., Rass, K., Seiter, S., Hauschild, A., Christophers, E., and Tilgen, W. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is no a reliable tumor marker in melanoma patients. J. Clin. Oncol., 15: 2828-2825, 1997.
20. Jung, F. A., Buzaid, A. C., Ross, M. I., Woods, K. V., Lee, J. J., Albitar, M., and Grimm, E. S. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. J. Clin. Oncol., 15: 2826-2831, 1997.
21. Ghossein, R. A., Coit, D., Brennan, M., Zhang, F. Z., Wang, Y., Bhattacharya, S., Houghtoin, A., and Rosai, J. Prognostic significance of peripheral blood and bone marrow tyrosinase mRNA in malignant melanoma. Clin. Cancer Res., 4: 419-428, 1998.
22. Saiki, R. K., Gelfand, D., Stoffel, S., et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (Washington DC), 230: 1350-1354, 1985.
23. Boyum, A. Separation of leukocytes from blood and bone marrow. Scand. Clin. Invest., 21: 51-55, 1968.
24. Chomczynski, P., and Sacchi, N. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
25. 4. Barth, A., and Morton, D. L. The role of adjuvant therapy in melanoma management. Cancer (Phila.), 75: 726-734, 1995.
26. Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., and Blum, R. H. Interferon α-2b adjuvant therapy of high-risk resected cutaneous melanoma. J. Clin. Oncol., 14: 7-17, 1996.
27. Livingston, P. O., Wong, G. Y. C., Adluri, S., Tao, Y., Padavan, M., Parente, R., Hanlow, C., Calves, M. J., Helling, F., and Ritter, G. Improved survival in stage III melanoma patients with GM2 antibodies. A randomized trial of adjuvant vaccination with GM2 ganglioside. J. Clin. Oncol., 12: 1036-1044, 1994.